Form 4: SOPHiA GENETICS SA Executive Sells Shares

Sentiment:

Insider Transaction (Form 4)


Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 20,000 shares of common stock on August 19, 2026.

Summary

  • Open-market sale: disposed of 10,000 Ordinary Shares at $7.94 ($79,427) on August 19, 2026; holds 576,887 after (Direct).
  • Open-market sale: disposed of 4,592 Ordinary Shares at $8.41 ($38,609) on August 20, 2026; holds 572,295 after (Direct).
  • Open-market sale: disposed of 5,408 Ordinary Shares at $8.40 ($45,447) on August 21, 2026; holds 566,887 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $163,482 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Zhenyu Xu — Officer (Chief Scientific Officer)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-08-19Open-market saleOrdinary Shares10,000$8$79.4K576,887
2026-08-20Open-market saleOrdinary Shares4,592$8$38.6K572,295
2026-08-21Open-market saleOrdinary Shares5,408$8$45.4K566,887

Key Dates

DateDescription
2026-08-19Open-market sale (10,000 shares)
2026-08-20Open-market sale (4,592 shares)
2026-08-21Open-market sale (5,408 shares)

Keywords

insider transaction, Form 4, SOPH, SOPHiA GENETICS SA, bearish, Zhenyu Xu

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.